IL17F and colorectal cancer: Positive relationships were observed between inflammatory bowel diseases, regarded as precancerous lesions of colorectal cancer, and IL-17A and IL-17F polymorphisms in several previous studies [24, 25], and an increasing number of studies have been performed to investigate whether these polymorphisms contribute to colorectal cancer; however, the results were still inconclusive.